Literature DB >> 22434915

A neural circuitry linking insulin resistance to depressed mood.

John P Ryan1, Lei K Sheu, Hugo D Critchley, Peter J Gianaros.   

Abstract

OBJECTIVE: Insulin resistance (IR) confers risk for Type 2 diabetes and is associated with depressed mood. Neurons within the ventral striatum (VS) are sensitive to insulin levels and show altered function in the context of both IR and depression. Hence, VS may represent a critical component of a neural circuitry linking IR to depressed mood.
METHODS: Ninety adults (aged 30-50 years) free from major psychiatric illnesses and diabetes participated. Fasting blood was sampled, and participants completed a set of questionnaires (including the Beck Depression Inventory-II). Participants also underwent resting-state functional magnetic resonance imaging of the brain. Seed-based connectivity analyses, centered on VS, were conducted to examine how resting-state interregional connectivity patterns covaried with IR and depressed mood.
RESULTS: Higher levels of IR covaried with increased connective strength between the left VS and two regions: the insula and the anterior midcingulate cortex (aMCC). Moreover, aMCC-VS connectivity predicted depressed mood (b = 0.93, standard error = 0.36, F(change)(1,81) = 6.54, p = .01). Finally, aMCC-VS connectivity was shown by Monte Carlo analysis to mediate the relationship between IR and depressed mood (a*b indirect effect = 0.16, confidence interval = 0.005-0.39, p = .03).
CONCLUSIONS: IR relates to changes in the functional connectivity between VS and aMCC. These changes in interregional communication partly account for the coupling of IR to depressed mood in otherwise healthy adults. These findings are relevant for understanding bidirectional associations between diabetes risk and depressed mood.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434915      PMCID: PMC3372626          DOI: 10.1097/PSY.0b013e31824d0865

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  48 in total

Review 1.  The primate basal ganglia: parallel and integrative networks.

Authors:  Suzanne N Haber
Journal:  J Chem Neuroanat       Date:  2003-12       Impact factor: 3.052

2.  Mediation in experimental and nonexperimental studies: new procedures and recommendations.

Authors:  Patrick E Shrout; Niall Bolger
Journal:  Psychol Methods       Date:  2002-12

Review 3.  Putting a spin on the dorsal-ventral divide of the striatum.

Authors:  Pieter Voorn; Louk J M J Vanderschuren; Henk J Groenewegen; Trevor W Robbins; Cyriel M A Pennartz
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

Review 4.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  Associations between depressive symptoms and insulin resistance: the Hoorn Study.

Authors:  M C Adriaanse; J M Dekker; G Nijpels; R J Heine; F J Snoek; F Pouwer
Journal:  Diabetologia       Date:  2006-10-26       Impact factor: 10.122

6.  Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?

Authors:  Karen Anthony; Laurence J Reed; Joel T Dunn; Emma Bingham; David Hopkins; Paul K Marsden; Stephanie A Amiel
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

7.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

8.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

9.  Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

Authors:  M Hallschmid; B Schultes
Journal:  Diabetologia       Date:  2009-08-25       Impact factor: 10.122

Review 10.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

View more
  18 in total

1.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

2.  Impact of impaired glucose metabolism on responses to a psychophysical stressor: modulation by ketamine.

Authors:  Brett Melanson; Thomas Lapointe; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2021-01-06       Impact factor: 4.530

3.  The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.

Authors:  Olivia I Okereke; Charles F Reynolds; David Mischoulon; Grace Chang; Nancy R Cook; Trisha Copeland; Georgina Friedenberg; Julie E Buring; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2018-03-08       Impact factor: 2.226

4.  Brain and behavioral correlates of insulin resistance in youth with depression and obesity.

Authors:  Manpreet K Singh; Sara M Leslie; Mary Melissa Packer; Yevgeniya V Zaiko; Owen R Phillips; Elizabeth F Weisman; Danielle M Wall; Booil Jo; Natalie Rasgon
Journal:  Horm Behav       Date:  2018-04-23       Impact factor: 3.587

5.  Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.

Authors:  Andre Kleinridders; Weikang Cai; Laura Cappellucci; Armen Ghazarian; William R Collins; Sara G Vienberg; Emmanuel N Pothos; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

6.  Insulin resistance is associated with smaller brain volumes in a preliminary study of depressed and obese children.

Authors:  Owen R Phillips; Alexander K Onopa; Yevgeniya V Zaiko; Manpreet K Singh
Journal:  Pediatr Diabetes       Date:  2018-05-08       Impact factor: 4.866

7.  Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice.

Authors:  Yeshwant Kurhe; R Mahesh; Thangaraj Devadoss
Journal:  Psychopharmacology (Berl)       Date:  2017-02-25       Impact factor: 4.530

8.  Basal ganglia morphology links the metabolic syndrome and depressive symptoms.

Authors:  Ikechukwu C Onyewuenyi; Matthew F Muldoon; Israel C Christie; Kirk I Erickson; Peter J Gianaros
Journal:  Physiol Behav       Date:  2013-10-04

9.  Insulin sensitivity predicts brain network connectivity following a meal.

Authors:  John P Ryan; Helmet T Karim; Howard J Aizenstein; Nicole L Helbling; Frederico G S Toledo
Journal:  Neuroimage       Date:  2018-01-13       Impact factor: 6.556

Review 10.  Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship?

Authors:  Rodrigo B Mansur; Danielle S Cha; Hanna O Woldeyohannes; Joanna K Soczynska; Andre Zugman; Elisa Brietzke; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2014-06-29       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.